259 related articles for article (PubMed ID: 22901357)
1. MAOIs and depression treatment guidelines.
Thase ME
J Clin Psychiatry; 2012 Jul; 73(7):e24. PubMed ID: 22901357
[TBL] [Abstract][Full Text] [Related]
2. The role of monoamine oxidase inhibitors in depression treatment guidelines.
Thase ME
J Clin Psychiatry; 2012; 73 Suppl 1():10-6. PubMed ID: 22951237
[TBL] [Abstract][Full Text] [Related]
3. The use of MAOIs in primary care.
Culpepper L
J Clin Psychiatry; 2012 May; 73(5):e19. PubMed ID: 22697202
[TBL] [Abstract][Full Text] [Related]
4. The use of monoamine oxidase inhibitors in primary care.
Culpepper L
J Clin Psychiatry; 2012; 73 Suppl 1():37-41. PubMed ID: 22951241
[TBL] [Abstract][Full Text] [Related]
5. MAOIs and transdermal delivery.
Vandenberg CM
J Clin Psychiatry; 2012 Sep; 73(9):e28. PubMed ID: 23059160
[TBL] [Abstract][Full Text] [Related]
6. The transdermal delivery system of monoamine oxidase inhibitors.
VanDenBerg CM
J Clin Psychiatry; 2012; 73 Suppl 1():25-30. PubMed ID: 22951239
[TBL] [Abstract][Full Text] [Related]
7. MAOIs: issues in treatment adherence and rates of treatment failure.
Cohen LJ; Sclar DA
J Clin Psychiatry; 2013 Jan; 74(1):e02. PubMed ID: 23419230
[TBL] [Abstract][Full Text] [Related]
8. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.
Flockhart DA
J Clin Psychiatry; 2012; 73 Suppl 1():17-24. PubMed ID: 22951238
[TBL] [Abstract][Full Text] [Related]
9. Current place of monoamine oxidase inhibitors in the treatment of depression.
Shulman KI; Herrmann N; Walker SE
CNS Drugs; 2013 Oct; 27(10):789-97. PubMed ID: 23934742
[TBL] [Abstract][Full Text] [Related]
10. Revisiting monoamine oxidase inhibitors.
Krishnan KR
J Clin Psychiatry; 2007; 68 Suppl 8():35-41. PubMed ID: 17640156
[TBL] [Abstract][Full Text] [Related]
11. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
Amsterdam JD; Bodkin JA
J Clin Psychopharmacol; 2006 Dec; 26(6):579-86. PubMed ID: 17110814
[TBL] [Abstract][Full Text] [Related]
12. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults.
Shulman KI; Fischer HD; Herrmann N; Huo CY; Anderson GM; Rochon PA
J Clin Psychiatry; 2009 Dec; 70(12):1681-6. PubMed ID: 19852903
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
Thomas SJ; Shin M; McInnis MG; Bostwick JR
Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
[TBL] [Abstract][Full Text] [Related]
14. Issues in adherence to treatment with monoamine oxidase inhibitors and the rate of treatment failure.
Cohen LJ; Sclar DA
J Clin Psychiatry; 2012; 73 Suppl 1():31-6. PubMed ID: 22951240
[TBL] [Abstract][Full Text] [Related]
15. Transdermal selegiline.
Patkar AA; Pae CU; Zarzar M
Drugs Today (Barc); 2007 Jun; 43(6):361-77. PubMed ID: 17612708
[TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase inhibitors: a new generation.
Robinson DS
Psychopharmacol Bull; 2002; 36(3):124-38. PubMed ID: 12473970
[TBL] [Abstract][Full Text] [Related]
17. Reversible monoamine oxidase-A inhibitors in resistant major depression.
Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
[TBL] [Abstract][Full Text] [Related]
18. What is the bottom line for dietary guidelines when taking monoamine oxidase inhibitors?
Marcason W
J Am Diet Assoc; 2005 Jan; 105(1):163. PubMed ID: 15635366
[No Abstract] [Full Text] [Related]
19. Drug therapy reviews: tricyclic antidepressant and monoamine oxidase inhibitor combination therapy.
Ponto LB; Perry PJ; Liskow BI; Seaba HH
Am J Hosp Pharm; 1977 Sep; 34(9):954-61. PubMed ID: 333909
[TBL] [Abstract][Full Text] [Related]
20. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
